483 Intas Pharmaceuticals Aug 2019

483 Intas Pharmaceuticals Aug 2019

Yasamin Ameri FDA, Thomas Arista FDA, Rita Kabaso FDA$119.00 - Available Now

FDA investigators audited the Intas Pharmaceuticals - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 02 Aug 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Aug 2019
  • Location: Ahmedabad, India
  • FEI: 3003157498
Add To Cart